Features and outcome of Pneumocystis carinii pneumonia according to risk category for HIV infection

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 1, 1997, Pages 57-61

  Laing, Robert ^a   Brettle, Raymond ^a   Leen, Clifford ^b   Hulks, Geoffrey ^c  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL FEATURE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT;

EID: 0030987183     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709008665     Document Type: Article

References (16)

1. Centres for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for people infected with HIV. JAMA 262: 335-339, 1989.
2. Kovacs JA, Masur H. Prophylaxis of Pneumocystis carinii pneumonia: an update. J Infect Dis 160: 882-886, 1989.
3. O'Donnell AE, Selig J, Aravamuthan M, Richardson MSA. Pulmonary complications associated with illicit drug use - an update. Chest 108: 460-463, 1995.
4. Brettle RP, Gore SM, McNeil A. Outpatient medical care of injection drug use related HIV. Int J STD AIDS 3: 96-100, 1992.
5. Hopewell PC. Pneumocystis carinii pneumonia: Diagnosis. J Infect Dis 157: 1115-1119, 1988.
6. Brenner M, Ognibene FP, Lack EE, Simmons JT, Suffredini AF, Lane HC, Fauci AS, Parrillo JE, Shelhamer JH, Masur H. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Resp Dis 136: 1199-1206, 1987.
7. Antinori A, Maiuro G, Pallavicini F, Ventura G, Marasca G, Murri R, Pizzigallo E, Camilli G, Tamburrini E. Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Eur J Epidemiol 9: 183-189, 1993.
8. Kales CP, Murren JR, Torres RA, Crocco JA. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 147: 1413-1417, 1987.
9. Sepkowitz KA, Telzak EE, Gold JWM, Bernard EM, Blum S, Carrow M, Dickmeyer M, Armstrong D. Pneumothorax in AIDS. Ann Intern Med 114: 455-459, 1991.
10. Broaddus C, Drake MD, Stulburg MS, Blumenfeld W, Hadley WK, Golden JA, Hopewell PC. Broncoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infection in the acquired immunodeficiency syndrome. Ann Intern Med 102: 747-752, 1986.
11. Elvin K. Laboratory diagnosis and occurrence of Pneumocystis carinii. Scand J Infect Dis Suppl 94: 1-34, 1994.
12. Leigh TR, Kirby K, Gazzard BG, Collins JV. Effect of sputum induction on arterial oxygen saturation and spirometry in HIV-infected patients. Eur Resp J 7: 435-438, 1994.
13. Willocks L, Cowan F, Brettle RP, Emmanuel PJ, Burns S. The spectrum of chest infections in HIV-positive patients in Edinburgh. J Infect 24: 37-42, 1992.
14. Lundgren JD, Barton SE, Katlama C, Ledregerber B, Gonzalez-Lahoz J, Pinching AJ, Proenca R, Hemmer R, Pedersen C, Phillips AN for the multicentre study group on AIDS in Europe. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with Acquired Immunodeficiency Syndrome. Arch Intern Med 155: 822-828, 1995.
15. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW. Survival trends for patients with AIDS. JAMA 263: 402-406, 1990.
16. Fischl MA, Richmann DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D and the AZT collaborative working group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 317: 185-191, 1987.